Brain metastasis from prostate cancer is rare. This case demonstrated a significant reduction in both primary and metastatic lesions following ADT-based endocrine therapy, with no significant adverse effects.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: